Synthesis and Cytotoxicity Assessment of 2 -(4 -Fluorophenyl)-N- halophenylacetamide Derivatives as Anticancer Agents
Authors
Abstract
Cancer is a group of diseases characterized by uncontrolled proliferation of abnormal cells. Because of the severe side effects and resistance to the traditional chemotherapeutic agents, the necessity for discovery of new anticancer drugs is a crucial topic. In the present study we synthesized new derivatives of 2-(4-Fluorophenyl)-N-halophenylacetamide and assessed their cytotoxicity against five cancerous cell lines consisted of PC3 (Prostate cancer), Hela (Cervical cancer), ACHN (Renal cell carcinoma), MCF-7 (Breast cancer) and HL-60 (Promyelocytic leukemia). All compounds demonstrated better cytotoxic activity towards PC3 cell line compared to other cell lines. Compound 2b showed the best cytotoxic effect in this series (IC50 = 102 μM/L). Replacement of butyl chain with phenyl ring led to the increase and improvement of the cytotoxic effects.
Copyright
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
2-(4-Fluorophenyl)-N-phenylacetamide Derivatives as Anticancer Agents: Synthesis and In-vitro Cytotoxicity Evaluation
Aliabadi A, Andisheh S, Tayarani-Najaran Z, Tayarani-Najaran M. 2-(4-Fluorophenyl)-N-phenylacetamide Derivatives as Anticancer Agents: Synthesis and In-vitro Cytotoxicity Evaluation. Iran J Pharm Res. 2013;12(3):e125688. doi: https://doi.org/10.22037/ijpr.2013.1326
N-(5-Mercapto-1,3,4-Thiadiazol-2-yl)-2-Phenylacetamide Derivatives: Synthesis and In-vitro Cytotoxicity Evaluation as Potential Anticancer Agents
Mohammadi-Farani A, Heidarian N, Aliabadi A. N-(5-Mercapto-1,3,4-Thiadiazol-2-yl)-2-Phenylacetamide Derivatives: Synthesis and In-vitro Cytotoxicity Evaluation as Potential Anticancer Agents. Iran J Pharm Res. 2014;13(2):e125547. doi: https://doi.org/10.22037/ijpr.2014.1503
Design, Synthesis and Biological Evaluation of 1,3-Diphenyl-3-(phenylthio)propan-1-ones as New Cytotoxic Agents
Bayanati M, Shahhosseini S, Shirazi FH, Farnam G, Zarghi A. Design, Synthesis and Biological Evaluation of 1,3-Diphenyl-3-(phenylthio)propan-1-ones as New Cytotoxic Agents. Iran J Pharm Res. 2021;20(4):e124535. doi: https://doi.org/10.22037/ijpr.2021.114865.15076
Synthesis and Cytotoxicity Evaluation of N-(5-mercapto-4H-1,2,4-triazol- 3-yl)-2-phenylacetamide Derivatives as Apoptosis Inducers with Potential Anticancer Effects
Mohammadi-Farani A, Zamani Mousavi HS, Hosseini A, Aliabadi A. Synthesis and Cytotoxicity Evaluation of N-(5-mercapto-4H-1,2,4-triazol- 3-yl)-2-phenylacetamide Derivatives as Apoptosis Inducers with Potential Anticancer Effects. J Rep Pharm Sci. 2020;9(1):e147310. doi: https://doi.org/10.4103/jrptps.JRPTPS_57_18
Synthesis and In-vitro Cytotoxicity Assessment of N-(5-(Benzylthio)-1,3,4- thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with Potential Anticancer Activity
Aliabadi A, Hasanvand Z, Kiani A, Mirabdali SS. Synthesis and In-vitro Cytotoxicity Assessment of N-(5-(Benzylthio)-1,3,4- thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with Potential Anticancer Activity. Iran J Pharm Res. 2013;12(4):e125741. doi: https://doi.org/10.22037/ijpr.2013.1363
More by these authors
- Scopus by DOI: 0
Last Update: 3 weeks ago
- Scopus by Title: 0
Last Update: 3 weeks ago
- Scopus by Title (Ref): 0
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 6 days ago